Core Viewpoint - The establishment of the "Junlebao-Jiangnan University Probiotic Joint Innovation Center" marks a significant milestone in the collaboration between Junlebao Dairy Group and Jiangnan University, focusing on probiotic research and development [1][3][10] Group 1: Collaboration and Objectives - The joint innovation center aims to address technical bottlenecks in the probiotic and postbiotic industries, promoting technological advancement in the sector [3] - Junlebao Dairy Group is committed to investing resources to ensure the center's operation and aims to create a virtuous cycle of "research promoting industry and industry enhancing research" [5][10] Group 2: Historical Collaboration and Achievements - Junlebao and Jiangnan University have a long-standing partnership, having collaborated on various projects over the years, including significant achievements in infant formula and fermented dairy products [5][6] - The joint efforts have led to the development of the high sn-2 DHA algal oil technology, recognized internationally for enhancing product nutritional value [5][6] Group 3: Scientific Innovation and Industry Development - Junlebao has invested 500 million yuan to establish a Scientific Nutrition Research Institute, aiming to create a world-class R&D platform [8] - The company has built a culture collection center with over 1,000 strains of quality lactic acid bacteria and has developed proprietary strains, filling gaps in the domestic market [8] - Junlebao's continuous transformation of cutting-edge scientific achievements into market-leading products has resulted in significant sales growth in low-temperature yogurt and high-end fresh milk [8]

Core Insights - The 2025 13th New Nutrition Conference was held in Hangzhou, Zhejiang, gathering over 1,000 industry experts and representatives to discuss cutting-edge research, innovative technologies, and applications in the nutrition and health sector [1] - A joint white paper titled "2025 China Maternal and Infant Source Probiotics Research and Application" was released by Aoyou, Jinqi Bio, and the Yili Innovation Center, highlighting the importance of maternal and infant probiotics in health and immune development [3][4] - Jinqi Bio's product, Yizhi Xian® dietary fiber probiotic powder, won the "Best-Selling Product Award" in the meal replacement and weight management category at the conference [1][6] Industry Trends - Probiotics research has become a significant topic in global nutrition and health, with a focus on maternal and infant probiotics as key regulators of the human microbiome [3] - The white paper emphasizes the unique characteristics of the gut microbiota in Chinese populations and discusses the clinical applications of specific probiotic strains in alleviating functional digestive disorders and reducing body fat [3][4] - The industry is moving towards standardization and regulation, with the white paper providing forward-looking insights on industry standards and future trends [3] Company Developments - Jinqi Bio has developed a complete industrial chain for the production and commercialization of high-value probiotic strains, including YLGB-1496 and CP-9, which have received multiple Chinese invention patents [4][5][6] - The company has successfully integrated these probiotics into various Yili products, such as yogurt, milk powder, ice cream, and cheese, receiving positive consumer feedback [6] - Jinqi Bio aims to continue innovating and developing high-quality probiotics to meet the diverse health needs of consumers, adhering to the principle of "using infant-level standards to create better probiotics" [9]